Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30+ Lymphoma-Reference-Cited by-同舟云学术

Cytomegalovirus Infection With Retinitis After Brentuximab Vedotin Treatment for CD30+ Lymphoma

Published:2017 Issue:2 Volume:4 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Tudesq Jean-Jacques¹²,Vincent Laure¹,Lebrun Julie³,Hicheri Yosr¹,Gabellier Ludovic¹,Busetto Timothé⁴,Merle Corinne⁵,Fegueux Nathalie¹,Ceballos Patrice¹,Quittet Philippe¹,Navarro Robert¹,Hillaire-Buys Dominique³,Cartron Guillaume¹²³⁴⁵

Affiliation:

1. Département d’Hématologie Clinique

2. Département de Réanimation Médicale et des Brûlés

3. Département de Pharmacologie Médicale et Toxicologie

4. Département d’Ophtalmologie, and

5. Département des Maladies Infectieuses et Tropicales, CHRU de Montpellier; and

Abstract

Abstract Brentuximab vedotin is an antibody-conjugated chemotherapy targeting CD30 indicated in treatment of several lymphomas. We report the first 3 cases of cytomegalovirus severe infections with retinitis following this treatment. Evolution was favorable, but relapse occurred after treatment rechallenge. We suggest vigilance about cytomegalovirus in patients treated with brentuximab vedotin.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/article-pdf/4/2/ofx091/33604569/ofx091.pdf

Reference20 articles.

1. CD30 in normal and neoplastic cells;Chiarle;Clin Immunol,1999

2. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity;Francisco;Blood,2003

3. U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma;de Claro;Clin Cancer Res,2012

4. Synergistic OX40 and CD30 signals sustain CD8+ T cells during antigenic challenge;Bekiaris;Eur J Immunol,2009

5. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis;Muta;J Immunol,2000

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review;Frontiers in Oncology;2024-08-05

2. Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Cureus;2024-01-10

3. Recommendations on prevention of infections in patients with T-cell lymphomas: a narrative review and synthesis;Leukemia & Lymphoma;2023-09-09

4. Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Life;2023-05-28

5. Brentuximab vedotin induced uveitis;American Journal of Ophthalmology Case Reports;2022-06